ReviewWorld journal of gastroenterology2025
Cystic tumors of the pancreas: Current perspectives on diagnosis and management.
Review in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pancreatic cystic lesions: position paper of the SIRM-AISP multidisciplinary group.La Radiologia medica · 2026Article
- Assessing Surveillance Practices for Incidental Pancreatic Cystic Lesions in a Rural Community Healthcare Network.Digestive diseases and sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic cystic lesions are being increasingly detected, mainly due to the widespread use of cross-sectional imaging. The reported prevalence ranges from 13% to 18% in asymptomatic individuals. These lesions display a broad histologic spectrum, from benign pseudocysts to premalignant mucinous cystic neoplasms and invasive carcinomas. Although many classification and management strategies exist, the natural history of numerous pancreatic cystic lesions remains incompletely understood, contributing to significant clinical uncertainty. Current diagnostic tools, including computed tomography, magnetic resonance imaging, endoscopic ultrasound, and cyst fluid analysis, are constrained by either suboptimal sensitivity or high costs. Cytology, while specific when positive, suffers from low sensitivity. Biochemical markers such as carcinoembryonic antigen, amylase, and glucose can help in cyst differentiation, whereas molecular testing (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.